Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC-IE): a novel, intensive induction chemotherapy regimen for patients with high-risk multiple myeloma.

Source:http://linkedlifedata.com/resource/pubmed/id/9074417

Download in:

View as

General Info

PMID
9074417